Related Experiment Video
Updated: Feb 28, 2026

Author Spotlight: Studying the Impact of Maternal Dietary Deficiencies on Long-Term Offspring Health Outcomes
Published on: June 28, 2024
[Fish oil in pregnancy: can it prevent asthma in children?]
1Isala Zwolle, Isala Vrouwkindcentrum, Zwolle.
Insights
Fish oil supplements during pregnancy may reduce childhood wheezing. However, study modifications and secondary outcomes raise concerns about routine recommendations for pregnant individuals.
Area of Science:
- Obstetrics and Gynecology
- Pediatric Allergy and Immunology
- Nutritional Science
Background:
- Prenatal supplementation with omega-3 fatty acids is explored for potential benefits in infant health.
- Asthma and allergic diseases are significant concerns in childhood development.
Purpose of the Study:
- To evaluate the effect of third-trimester fish oil supplementation on wheezing and asthma in children.
- To assess the impact on allergic sensitization and eczema development.
Main Methods:
- A randomized clinical trial involving pregnant individuals receiving fish oil supplements.
- Follow-up of children to assess respiratory symptoms and allergic outcomes up to 3-5 years of age.
Main Results:
- A significant association was found between third-trimester fish oil intake and reduced wheezing or asthma in children aged 3-5 years.
- However, key primary endpoints were modified post-hoc, and no significant effects were observed for eczema or allergic sensitization.
Conclusions:
- While a potential benefit for reducing childhood wheeze was suggested, methodological concerns and secondary outcome results limit the interpretation.
- The study does not provide sufficient evidence to recommend routine fish oil supplementation during pregnancy for preventing childhood respiratory issues.
Abstract:
Taking fish oil supplements in the third trimester of pregnancy was associated with significantly less wheezing or asthma in the child at the age of 3-5 years, according to a randomized clinical trial by Bisgaard et al., NEJM 2017. However, the results of this study should be interpreted with caution. The primary end points were modified at a late stage in the study, and two primary end points, eczema in the first 3 years of life and allergic sensitization at 18 months of age, were demoted to secondary end points, and showed no significant effect of treatment. Furthermore, the age range for the published primary end point, persistent wheeze, differed from that in the protocol. Additional concerns include the emphasis on outcomes by omega-3 fatty acid levels in the blood, a post hoc subgroup analysis not included in the protocol. In our opinion, this study does not justify advising routine fish oil supplements in pregnancy.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
11:08The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Related Concept Videos
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-I: Introduction
Asthma-IV: Nursing Management
First, in...